Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
- PMID: 19064563
- PMCID: PMC2600618
- DOI: 10.1158/1055-9965.EPI-08-0514
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
Abstract
Insulin-like growth factors (IGF) have been associated with risk of common human cancers, but the association between IGFs and pancreatic cancer risk is unclear. To determine whether genetic variations of IGF modify pancreatic cancer risk, we compared the frequency of six single nucleotide polymorphisms of IGF1 and IGF2 in a large-scale case control study. Single nucleotide polymorphisms were investigated using the TaqMan method in 892 patients with pancreatic ductal adenocarcinoma and 783 healthy controls who were recruited from The University of Texas M. D. Anderson Cancer Center from 2000 to 2007. Cases and controls were frequency matched by age (+/-5 years), race, and sex. Risk factor information was collected using direct interviews. We estimated odds ratios (OR) and 95% confidence intervals (95% CI) using unconditional multivariate logistic regression models. A haplotype of IGF1 gene containing the 3'-UTR Ex4 -177 G>C G allele had a significantly lower frequency in cases (0.027) than in controls (0.041; P = 0.039). A statistically significant joint effect of the IGF1 3'-UTR Ex4 -177 G>C C allele and diabetes on pancreatic cancer risk was observed. The OR (95% CI) were 1.07 (0.81-1.42), 2.12 (1.53-2.93), and 5.69 (2.63-12.3) for individuals who had the CC/CG genotype alone, diabetes alone, or both factors, respectively, compared with subjects without either of the two factors with adjustment for other risk factors. The IGF2 3'-UTR Ex4 -233C>T TT genotype was significantly associated with a reduced risk of pancreatic cancer (OR = 0.07; 95% CI = 0.01-0.57; P = 0.013). The polymorphic variants of the IGF genes may serve as a susceptibility factor for pancreatic cancer.
Similar articles
-
Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.Cancer Epidemiol. 2012 Apr;36(2):206-11. doi: 10.1016/j.canep.2011.05.013. Epub 2011 Aug 17. Cancer Epidemiol. 2012. PMID: 21852217
-
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3. doi: 10.1053/j.gastro.2010.04.042. Epub 2010 Apr 21. Gastroenterology. 2010. PMID: 20416304 Free PMC article.
-
Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.World J Gastroenterol. 2014 Dec 14;20(46):17456-62. doi: 10.3748/wjg.v20.i46.17456. World J Gastroenterol. 2014. PMID: 25516658 Free PMC article.
-
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1470-6. doi: 10.1158/1055-9965.EPI-04-0894. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15941958
-
Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.J Natl Cancer Inst. 2006 Jan 18;98(2):123-34. doi: 10.1093/jnci/djj013. J Natl Cancer Inst. 2006. PMID: 16418515
Cited by
-
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2298-306. doi: 10.1158/1055-9965.EPI-10-0400. Epub 2010 Aug 10. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20699371 Free PMC article.
-
Methylation of a newly identified region of the INS-IGF2 gene determines IGF2 expression in breast cancer tumors and in breast cancer cells.Onco_target. 2020 Nov 3;11(44):3904-3920. doi: 10.18632/onco_target.27655. eCollection 2020 Nov 3. Onco_target. 2020. PMID: 33216823 Free PMC article.
-
Glucose metabolism gene variants modulate the risk of pancreatic cancer.Cancer Prev Res (Phila). 2011 May;4(5):758-66. doi: 10.1158/1940-6207.CAPR-10-0247. Epub 2011 Mar 16. Cancer Prev Res (Phila). 2011. PMID: 21411499 Free PMC article.
-
Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors.J Korean Surg Soc. 2012 May;82(5):288-95. doi: 10.4174/jkss.2012.82.5.288. Epub 2012 Apr 26. J Korean Surg Soc. 2012. PMID: 22563535 Free PMC article.
-
An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies.J Epidemiol. 2011;21(1):2-12. doi: 10.2188/jea.je20100090. Epub 2010 Nov 6. J Epidemiol. 2011. PMID: 21071884 Free PMC article. Review.
References
-
- American Cancer Society . Cancer Figures and Facts. American Cancer Society; Atlanta, GA: 2007.
-
- Anderson K, Potter JD, Mack TM. Pancreatic Cancer. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 725−771. Oxford University Press; New York, NY: 2006.
-
- Duell EJ, Holly EA, Bracci PM, et al. A population-based, case–control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst. 2002;94:297–306. - PubMed
-
- Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 [XRCC1] and risk of pancreatic adenocarcinoma. Cancer Res. 2002;62:4630–4636. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous